🇺🇸 FDA

Drug profile · INN

pentagastrin

PEPTAVLON

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

pentagastrin (PEPTAVLON) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN pentagastrin
Brand PEPTAVLON
Route INJECTION
Formulation INJECTABLE

Related patents

Search patents →

  1. US 8853356

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7807623

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7365047

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is pentagastrin?

pentagastrin (PEPTAVLON) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for pentagastrin?

PEPTAVLON is a marketed brand name for pentagastrin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pentagastrin?

pentagastrin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.